SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2o36'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ERR_A_CCSA381_0
(ESTROGEN RECEPTOR)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 5 GLU A 652
ALA A 486
SER A 484
HIS A 480
None
1.12A 1errA-2o36A:
undetectable
1errB-2o36A:
undetectable
1errA-2o36A:
17.51
1errB-2o36A:
17.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1G50_A_ESTA600_1
(ESTROGEN RECEPTOR)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 11 LEU A 295
LEU A 298
ALA A 299
LEU A 552
LEU A 579
None
1.07A 1g50A-2o36A:
undetectable
1g50A-2o36A:
17.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GWR_A_ESTA600_1
(OESTROGEN RECEPTOR)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 10 LEU A 295
LEU A 298
ALA A 299
LEU A 552
LEU A 579
None
1.20A 1gwrA-2o36A:
undetectable
1gwrA-2o36A:
17.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HZ4_A_BEZA784_0
(MALT REGULATORY
PROTEIN)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 6 HIS A 223
LEU A 196
LEU A 199
PRO A 200
None
1.04A 1hz4A-2o36A:
undetectable
1hz4A-2o36A:
22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J36_A_LPRA801_1
(ANGIOTENSIN
CONVERTING ENZYME)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 12 THR A 470
HIS A 473
GLU A 474
HIS A 477
GLU A 502
None
ZN  A 690 (-3.4A)
ZN  A 690 ( 4.1A)
ZN  A 690 (-3.3A)
ZN  A 690 (-2.3A)
0.44A 1j36A-2o36A:
18.4
1j36A-2o36A:
22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J36_A_LPRA801_1
(ANGIOTENSIN
CONVERTING ENZYME)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 12 THR A 470
HIS A 473
GLU A 474
HIS A 477
TYR A 612
None
ZN  A 690 (-3.4A)
ZN  A 690 ( 4.1A)
ZN  A 690 (-3.3A)
None
0.99A 1j36A-2o36A:
18.4
1j36A-2o36A:
22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J36_B_LPRB802_1
(ANGIOTENSIN
CONVERTING ENZYME)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 12 THR A 470
HIS A 473
GLU A 474
HIS A 477
GLU A 502
None
ZN  A 690 (-3.4A)
ZN  A 690 ( 4.1A)
ZN  A 690 (-3.3A)
ZN  A 690 (-2.3A)
0.45A 1j36B-2o36A:
17.7
1j36B-2o36A:
22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J36_B_LPRB802_1
(ANGIOTENSIN
CONVERTING ENZYME)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 12 THR A 470
HIS A 473
GLU A 474
HIS A 477
TYR A 612
None
ZN  A 690 (-3.4A)
ZN  A 690 ( 4.1A)
ZN  A 690 (-3.3A)
None
0.99A 1j36B-2o36A:
17.7
1j36B-2o36A:
22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J37_A_X8ZA801_1
(ANGIOTENSIN
CONVERTING ENZYME)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 11 GLU A 502
HIS A 473
GLU A 474
PHE A 428
TYR A 422
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 ( 4.1A)
None
None
1.30A 1j37A-2o36A:
18.2
1j37A-2o36A:
22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J37_B_X8ZB802_1
(ANGIOTENSIN
CONVERTING ENZYME)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 11 GLU A 502
HIS A 473
GLU A 474
PHE A 428
TYR A 422
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 ( 4.1A)
None
None
1.30A 1j37B-2o36A:
17.9
1j37B-2o36A:
22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1O86_A_LPRA702_1
(ANGIOTENSIN
CONVERTING ENZYME)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 12 GLU A 502
HIS A 473
GLU A 474
PHE A 428
TYR A 422
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 ( 4.1A)
None
None
1.31A 1o86A-2o36A:
18.5
1o86A-2o36A:
22.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V55_C_CHDC3271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE III
CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 7 LEU A 564
GLN A 567
LEU A 601
PHE A 598
None
1.03A 1v55C-2o36A:
4.3
1v55J-2o36A:
undetectable
1v55C-2o36A:
17.45
1v55J-2o36A:
7.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V55_P_CHDP4271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE III
CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 7 LEU A 564
GLN A 567
LEU A 601
PHE A 598
None
1.01A 1v55P-2o36A:
4.9
1v55W-2o36A:
undetectable
1v55P-2o36A:
17.45
1v55W-2o36A:
7.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V7Z_A_CRNA401_1
(CREATININE
AMIDOHYDROLASE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 8 GLU A 502
HIS A 473
HIS A 477
GLU A 474
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 (-3.3A)
ZN  A 690 ( 4.1A)
0.88A 1v7zA-2o36A:
undetectable
1v7zA-2o36A:
16.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V7Z_B_CRNB3401_1
(CREATININE
AMIDOHYDROLASE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 8 GLU A 502
HIS A 473
HIS A 477
GLU A 474
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 (-3.3A)
ZN  A 690 ( 4.1A)
0.88A 1v7zB-2o36A:
undetectable
1v7zB-2o36A:
16.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V7Z_C_CRNC4401_1
(CREATININE
AMIDOHYDROLASE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 8 GLU A 502
HIS A 473
HIS A 477
GLU A 474
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 (-3.3A)
ZN  A 690 ( 4.1A)
0.89A 1v7zC-2o36A:
undetectable
1v7zC-2o36A:
16.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V7Z_D_CRND5401_1
(CREATININE
AMIDOHYDROLASE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 8 GLU A 502
HIS A 473
HIS A 477
GLU A 474
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 (-3.3A)
ZN  A 690 ( 4.1A)
0.91A 1v7zD-2o36A:
undetectable
1v7zD-2o36A:
16.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V7Z_E_CRNE6401_1
(CREATININE
AMIDOHYDROLASE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 8 GLU A 502
HIS A 473
HIS A 477
GLU A 474
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 (-3.3A)
ZN  A 690 ( 4.1A)
0.90A 1v7zE-2o36A:
undetectable
1v7zE-2o36A:
16.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V7Z_F_CRNF7401_1
(CREATININE
AMIDOHYDROLASE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 8 GLU A 502
HIS A 473
HIS A 477
GLU A 474
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 (-3.3A)
ZN  A 690 ( 4.1A)
0.89A 1v7zF-2o36A:
undetectable
1v7zF-2o36A:
16.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C6N_A_LPRA705_1
(ANGIOTENSIN-CONVERTI
NG ENZYME, SOMATIC
ISOFORM)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 12 ALA A 425
HIS A 473
GLU A 474
HIS A 477
GLU A 502
None
ZN  A 690 (-3.4A)
ZN  A 690 ( 4.1A)
ZN  A 690 (-3.3A)
ZN  A 690 (-2.3A)
0.55A 2c6nA-2o36A:
16.3
2c6nA-2o36A:
23.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C6N_A_LPRA705_1
(ANGIOTENSIN-CONVERTI
NG ENZYME, SOMATIC
ISOFORM)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 12 ALA A 425
HIS A 473
GLU A 474
HIS A 477
TYR A 612
None
ZN  A 690 (-3.4A)
ZN  A 690 ( 4.1A)
ZN  A 690 (-3.3A)
None
1.24A 2c6nA-2o36A:
16.3
2c6nA-2o36A:
23.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DYS_C_CHDC310_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 7 LEU A 564
GLN A 567
LEU A 601
PHE A 598
None
0.93A 2dysC-2o36A:
4.9
2dysJ-2o36A:
undetectable
2dysC-2o36A:
17.45
2dysJ-2o36A:
7.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIJ_C_CHDC271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 7 LEU A 564
GLN A 567
LEU A 601
PHE A 598
None
1.00A 2eijC-2o36A:
4.9
2eijJ-2o36A:
undetectable
2eijC-2o36A:
17.45
2eijJ-2o36A:
7.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIM_C_CHDC271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 7 LEU A 564
GLN A 567
LEU A 601
PHE A 598
None
0.98A 2eimC-2o36A:
3.5
2eimJ-2o36A:
undetectable
2eimC-2o36A:
17.45
2eimJ-2o36A:
7.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIN_C_CHDC271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 7 LEU A 564
GLN A 567
LEU A 601
PHE A 598
None
1.02A 2einC-2o36A:
3.4
2einJ-2o36A:
undetectable
2einC-2o36A:
17.45
2einJ-2o36A:
7.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIN_P_CHDP1271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART
CYTOCHROME C OXIDASE
SUBUNIT 3)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 6 LEU A 564
GLN A 567
LEU A 601
PHE A 598
None
1.00A 2einP-2o36A:
3.4
2einW-2o36A:
undetectable
2einP-2o36A:
17.45
2einW-2o36A:
7.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2GJ5_A_VD3A164_1
(BETA-LACTOGLOBULIN)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 5 ASP A 102
LEU A 105
LYS A 104
ARG A  79
None
1.43A 2gj5A-2o36A:
undetectable
2gj5A-2o36A:
14.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JIH_B_097B1001_1
(ADAMTS-1)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 8 THR A 470
HIS A 473
GLU A 474
HIS A 477
None
ZN  A 690 (-3.4A)
ZN  A 690 ( 4.1A)
ZN  A 690 (-3.3A)
0.30A 2jihB-2o36A:
2.3
2jihB-2o36A:
18.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JN3_A_JN3A130_2
(FATTY ACID-BINDING
PROTEIN, LIVER)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 7 LEU A 376
LEU A 377
ARG A 647
GLU A 630
ARG A 626
None
1.43A 2jn3A-2o36A:
undetectable
2jn3A-2o36A:
11.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QHF_A_ACTA509_0
(CHORISMATE SYNTHASE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
3 / 3 ARG A 333
GLN A 581
PRO A 587
None
1.01A 2qhfA-2o36A:
undetectable
2qhfA-2o36A:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QM9_A_TDZA201_1
(FATTY ACID-BINDING
PROTEIN, ADIPOCYTE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 12 PHE A  84
VAL A 394
ALA A 447
ASP A 414
ARG A 418
None
1.39A 2qm9A-2o36A:
undetectable
2qm9A-2o36A:
10.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X91_A_LPRA1615_1
(ANGIOTENSIN
CONVERTING ENZYME)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 12 HIS A 473
GLU A 474
HIS A 477
GLU A 502
TYR A 612
ZN  A 690 (-3.4A)
ZN  A 690 ( 4.1A)
ZN  A 690 (-3.3A)
ZN  A 690 (-2.3A)
None
1.13A 2x91A-2o36A:
18.2
2x91A-2o36A:
22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XZ5_D_ACHD1211_0
(SOLUBLE
ACETYLCHOLINE
RECEPTOR)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 8 GLN A 562
GLN A 668
ASP A 296
TYR A 609
None
1.27A 2xz5C-2o36A:
undetectable
2xz5D-2o36A:
undetectable
2xz5C-2o36A:
15.70
2xz5D-2o36A:
15.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YVL_B_SAMB602_1
(HYPOTHETICAL PROTEIN)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
3 / 3 GLU A 111
ASP A 109
TYR A  75
None
0.55A 2yvlB-2o36A:
undetectable
2yvlB-2o36A:
18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZXW_C_CHDC271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 3)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 7 LEU A 564
GLN A 567
LEU A 601
PHE A 598
None
0.94A 2zxwC-2o36A:
2.8
2zxwJ-2o36A:
undetectable
2zxwC-2o36A:
17.45
2zxwJ-2o36A:
7.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A6J_A_CRNA303_1
(CREATININE
AMIDOHYDROLASE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 8 GLU A 502
HIS A 473
HIS A 477
GLU A 474
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 (-3.3A)
ZN  A 690 ( 4.1A)
0.89A 3a6jA-2o36A:
undetectable
3a6jA-2o36A:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A6J_B_CRNB304_1
(CREATININE
AMIDOHYDROLASE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 7 GLU A 502
HIS A 473
HIS A 477
GLU A 474
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 (-3.3A)
ZN  A 690 ( 4.1A)
0.87A 3a6jB-2o36A:
undetectable
3a6jB-2o36A:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A6J_C_CRNC305_1
(CREATININE
AMIDOHYDROLASE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 8 GLU A 502
HIS A 473
HIS A 477
GLU A 474
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 (-3.3A)
ZN  A 690 ( 4.1A)
0.87A 3a6jC-2o36A:
undetectable
3a6jC-2o36A:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A6J_E_CRNE306_1
(CREATININE
AMIDOHYDROLASE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 8 GLU A 502
HIS A 473
HIS A 477
GLU A 474
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 (-3.3A)
ZN  A 690 ( 4.1A)
0.90A 3a6jE-2o36A:
undetectable
3a6jE-2o36A:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A6J_F_CRNF307_1
(CREATININE
AMIDOHYDROLASE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 8 GLU A 502
HIS A 473
HIS A 477
GLU A 474
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 (-3.3A)
ZN  A 690 ( 4.1A)
0.87A 3a6jF-2o36A:
undetectable
3a6jF-2o36A:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG1_C_CHDC271_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 3)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 6 LEU A 564
GLN A 567
LEU A 601
PHE A 598
None
0.97A 3ag1C-2o36A:
3.4
3ag1J-2o36A:
undetectable
3ag1C-2o36A:
17.45
3ag1J-2o36A:
7.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWQ_C_VIAC901_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
CATALYTIC DOMAIN,
CONE CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
SUBUNIT ALPHA
CHIMERA)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 7 TYR A 609
HIS A 600
LEU A 280
VAL A 501
None
1.13A 3jwqC-2o36A:
undetectable
3jwqC-2o36A:
20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KEC_B_HAEB271_1
(COLLAGENASE 3)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
3 / 3 HIS A 473
GLU A 474
HIS A 477
ZN  A 690 (-3.4A)
ZN  A 690 ( 4.1A)
ZN  A 690 (-3.3A)
0.19A 3kecB-2o36A:
3.5
3kecB-2o36A:
13.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NV6_A_CAMA422_0
(CYTOCHROME P450)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
3 / 3 GLY A 585
ILE A 555
VAL A 556
None
0.33A 3nv6A-2o36A:
2.4
3nv6A-2o36A:
21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PGY_B_GLYB511_0
(SERINE
HYDROXYMETHYLTRANSFE
RASE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 5 SER A 461
GLU A 467
LEU A 463
GLN A 464
LYS A 357
None
1.01A 3pgyB-2o36A:
0.0
3pgyB-2o36A:
20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C2P_A_X8ZA709_1
(ANGIOTENSIN-CONVERTI
NG ENZYME)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 11 GLU A 502
HIS A 473
GLU A 474
PHE A 428
TYR A 422
ZN  A 690 (-2.3A)
ZN  A 690 (-3.4A)
ZN  A 690 ( 4.1A)
None
None
1.28A 4c2pA-2o36A:
18.7
4c2pA-2o36A:
22.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B1B_P_CHDP306_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 7 LEU A 564
GLN A 567
LEU A 601
PHE A 598
None
0.91A 5b1bP-2o36A:
4.7
5b1bW-2o36A:
undetectable
5b1bP-2o36A:
17.45
5b1bW-2o36A:
7.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSD_A_1GNA607_1
(PHIAB6 TAILSPIKE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
3 / 3 THR A 527
SER A 529
TYR A 359
None
0.84A 5jsdA-2o36A:
undetectable
5jsdA-2o36A:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSD_B_1GNB618_1
(PHIAB6 TAILSPIKE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
3 / 3 THR A 527
SER A 529
TYR A 359
None
0.83A 5jsdB-2o36A:
undetectable
5jsdB-2o36A:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSD_C_1GNC608_1
(PHIAB6 TAILSPIKE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
3 / 3 THR A 527
SER A 529
TYR A 359
None
0.84A 5jsdC-2o36A:
undetectable
5jsdC-2o36A:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSE_A_1GNA608_1
(PHIAB6 TAILSPIKE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
3 / 3 THR A 527
SER A 529
TYR A 359
None
0.82A 5jseA-2o36A:
undetectable
5jseA-2o36A:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSE_B_1GNB611_1
(PHIAB6 TAILSPIKE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
3 / 3 THR A 527
SER A 529
TYR A 359
None
0.81A 5jseB-2o36A:
undetectable
5jseB-2o36A:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSE_C_1GNC611_1
(PHIAB6 TAILSPIKE)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
3 / 3 THR A 527
SER A 529
TYR A 359
None
0.82A 5jseC-2o36A:
undetectable
5jseC-2o36A:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LI8_A_KKKA502_1
(PUTATIVE CYTOCHROME
P450 126)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
5 / 12 THR A 592
ASN A 183
ALA A 602
ARG A 247
ASN A 593
None
1.36A 5li8A-2o36A:
0.9
5li8A-2o36A:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MFX_A_ACTA701_0
(GENOME POLYPROTEIN)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 5 THR A 274
HIS A 275
ALA A 276
ASP A 277
None
1.44A 5mfxA-2o36A:
undetectable
5mfxA-2o36A:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z3J_A_NCAA302_0
(ABRIN A-CHAIN)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 6 VAL A 556
ILE A 583
GLU A 582
ARG A 578
None
0.76A 5z3jA-2o36A:
undetectable
5z3jA-2o36A:
18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BC9_A_ETSA302_2
(CARBONIC ANHYDRASE 2)
2o36 THIMET
OLIGOPEPTIDASE

(Homo
sapiens)
4 / 5 HIS A  87
GLU A 474
HIS A 477
VAL A 501
None
ZN  A 690 ( 4.1A)
ZN  A 690 (-3.3A)
None
1.14A 6bc9A-2o36A:
undetectable
6bc9A-2o36A:
9.57